Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis. Am J Hematol 2015 Nov;90(11):E212-3

Date

08/19/2015

Pubmed ID

26284951

Pubmed Central ID

PMC4618044

DOI

10.1002/ajh.24176

Scopus ID

2-s2.0-84944536944   6 Citations

Author List

Hussain AS, Hari P, Brazauskas R, Arce-Lara C, Pasquini M, Hamadani M, D'Souza A

Authors

Ruta Brazauskas PhD Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin
Anita D'Souza MD Associate Professor in the Medicine department at Medical College of Wisconsin
Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Chief, Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Aged, 80 and over
Amyloidosis
Antineoplastic Agents
Biomarkers
Bortezomib
Creatinine
Cyclophosphamide
Dexamethasone
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Myocardium
Natriuretic Peptide, Brain
Peptide Fragments
Prognosis
Severity of Illness Index
Troponin T
jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a